97 related articles for article (PubMed ID: 22245330)
1. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
[TBL] [Abstract][Full Text] [Related]
2. Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
Pires-Luís AS; Costa-Pinheiro P; Ferreira MJ; Antunes L; Lobo F; Oliveira J; Henrique R; Jerónimo C
J Transl Med; 2017 Jun; 15(1):149. PubMed ID: 28662726
[TBL] [Abstract][Full Text] [Related]
3. Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients.
Walentowicz-Sadlecka M; Sadlecki P; Bodnar M; Marszalek A; Walentowicz P; Sokup A; Wilińska-Jankowska A; Grabiec M
PLoS One; 2014; 9(1):e84629. PubMed ID: 24416254
[TBL] [Abstract][Full Text] [Related]
4. A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration.
Lau S; Feitzinger A; Venkiteswaran G; Wang J; Lewellis SW; Koplinski CA; Peterson FC; Volkman BF; Meier-Schellersheim M; Knaut H
Nat Cell Biol; 2020 Mar; 22(3):266-273. PubMed ID: 32042179
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues.
Zhang J; Li SQ; Lin JQ; Yu W; Eberlin LS
Cancer Res; 2020 Feb; 80(4):689-698. PubMed ID: 31843980
[TBL] [Abstract][Full Text] [Related]
6. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract][Full Text] [Related]
7. High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo.
Wang J; Huang Y; Zhang J; Xing B; Xuan W; Wang H; Huang H; Yang J; Tang J
Cell Commun Signal; 2018 May; 16(1):22. PubMed ID: 29783989
[TBL] [Abstract][Full Text] [Related]
8. An emerging paradigm of CXCL12 involvement in the metastatic cascade.
Anastasiadou DP; Quesnel A; Duran CL; Filippou PS; Karagiannis GS
Cytokine Growth Factor Rev; 2024 Feb; 75():12-30. PubMed ID: 37949685
[TBL] [Abstract][Full Text] [Related]
9. Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue.
Venkiteswaran G; Lewellis SW; Wang J; Reynolds E; Nicholson C; Knaut H
Cell; 2013 Oct; 155(3):674-87. PubMed ID: 24119842
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer.
Akashi T; Koizumi K; Tsuneyama K; Saiki I; Takano Y; Fuse H
Cancer Sci; 2008 Mar; 99(3):539-42. PubMed ID: 18201276
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer
Zhao S; Chang SL; Linderman JJ; Feng FY; Luker GD
Transl Oncol; 2014 May; 7(3):429-38. PubMed ID: 24836649
[TBL] [Abstract][Full Text] [Related]
12. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.
Jorge S; Capelo JL; LaFramboise W; Satturwar S; Korentzelos D; Bastacky S; Quiroga-Garza G; Dhir R; Wiśniewski JR; Lodeiro C; Santos HM
BMC Med; 2021 Sep; 19(1):196. PubMed ID: 34482820
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
Kovaleva OV; Podlesnaya PA; Mochalnikova VV; Kushlinskii NE; Khromykh LM; Kalinina AA; Kazansky DB; Gratchev AN
Bull Exp Biol Med; 2024 Jan; 176(3):382-385. PubMed ID: 38340200
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
[TBL] [Abstract][Full Text] [Related]
15. Identification of AKI signatures and classification patterns in ccRCC based on machine learning.
Wang L; Peng F; Li ZH; Deng YF; Ruan MN; Mao ZG; Li L
Front Med (Lausanne); 2023; 10():1195678. PubMed ID: 37293297
[TBL] [Abstract][Full Text] [Related]
16. Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.
Jiang S; Luo M; Bai X; Nie P; Zhu Y; Cai H; Li B; Luo P
J Cell Commun Signal; 2022 Sep; 16(3):313-331. PubMed ID: 35041192
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer.
Bialek J; Piwonka M; Kawan F; Fornara P; Theil G
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440475
[TBL] [Abstract][Full Text] [Related]
18. The Role of CXCL12 in Kidney Diseases: A Friend or Foe?
Song A; Jiang A; Xiong W; Zhang C
Kidney Dis (Basel); 2021 May; 7(3):176-185. PubMed ID: 34179113
[TBL] [Abstract][Full Text] [Related]
19. CXCL12γ induces human prostate and mammary gland development.
Jung Y; Kim JK; Lee E; Cackowski FC; Decker AM; Krebsbach PH; Taichman RS
Prostate; 2020 Sep; 80(13):1145-1156. PubMed ID: 32659025
[TBL] [Abstract][Full Text] [Related]
20. A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients.
Mitchell A; Hasanali SL; Morera DS; Baskar R; Wang X; Khan R; Talukder A; Li CS; Manoharan M; Jordan AR; Wang J; Bollag RJ; Singh N; Albo D; Ghosh S; Lokeshwar VB
Cancer Biomark; 2019; 26(3):291-301. PubMed ID: 31524146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
